0001387131-21-000041.txt : 20210104
0001387131-21-000041.hdr.sgml : 20210104
20210104170125
ACCESSION NUMBER: 0001387131-21-000041
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201230
FILED AS OF DATE: 20210104
DATE AS OF CHANGE: 20210104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEDERMAN SETH
CENTRAL INDEX KEY: 0001563420
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36019
FILM NUMBER: 21502545
MAIL ADDRESS:
STREET 1: C/O TONIX PHARMACEUTICALS HOLDING CORP
STREET 2: 509 MADISON AVE., SUITE 306
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tonix Pharmaceuticals Holding Corp.
CENTRAL INDEX KEY: 0001430306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261434750
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 28 MAIN STREET
CITY: CHATHAM
STATE: NJ
ZIP: 07928
BUSINESS PHONE: 212-980-9155
MAIL ADDRESS:
STREET 1: 28 MAIN STREET
CITY: CHATHAM
STATE: NJ
ZIP: 07928
FORMER COMPANY:
FORMER CONFORMED NAME: TAMANDARE EXPLORATIONS INC.
DATE OF NAME CHANGE: 20080320
4
1
lederman-form4_123020.xml
CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2020-12-30
0
0001430306
Tonix Pharmaceuticals Holding Corp.
TNXP
0001563420
LEDERMAN SETH
C/O TONIX PHARMACEUTICALS HOLDING CORP
26 MAIN STREET, SUITE 101
CHATHAM
NJ
07928
1
1
0
0
Chief Executive Officer
Common Stock, $0.001 par value
2020-12-30
4
P
0
35000
0.68
A
118267
D
Common Stock, $0.001 par value
459
D
Common Stock, $0.001 par value
177
D
Common Stock, $0.001 par value
31
I
By spouse
Common Stock, $0.001 par value
30
I
By Leder Laboratories, Inc.
Common Stock, $0.001 par value
30
I
By Starling Pharmaceuticals, Inc.
Common Stock, $0.001 par value
205
I
By Lederman & Co., LLC
Common Stock, $0.001 par value
33
I
By L&L Technologies, LLC
Common Stock, $0.001 par value
59
I
By Targent Pharmaceuticals, LLC
The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $0.6801 to $0.6805, inclusive. The reporting person undertakes to provide to Tonix Pharmaceuticals Holding Corp., any security holder of Tonix Pharmaceuticals Holding Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
Reporting person may be deemed to be a control person of this entity.
/s/ Seth Lederman
2020-12-30